Scarica l'app Stockscreener
0.2315
4.77%
0.0112
Precedente Chiudi:
$0.2203
Aprire:
$0.2286
Volume 24 ore:
62.62M
Relative Volume:
1.07
Capitalizzazione di mercato:
$42.27M
Reddito:
-
Utile/perdita netta:
$-21.91M
Rapporto P/E:
-0.1554
EPS:
-1.49
Flusso di cassa netto:
-
1 W Prestazione:
+9.75%
1M Prestazione:
+11.93%
6M Prestazione:
-86.96%
1 anno Prestazione:
-91.59%
Intervallo 1D:
$0.223
$0.235
Intervallo di 1 settimana:
$0.2081
$0.244
Portata 52W:
$0.08
$3.1199
Incannex Healthcare Inc Stock (IXHL) Company Profile
Nome
Incannex Healthcare Inc
Settore
Telefono
61 409 840 786
Indirizzo
8 CENTURY CIRCUIT, NORWEST NSW
Confronta IXHL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
0.2313 | 19.70M | 0 | -21.91M | 0 | -1.49 |
|
ZTS
Zoetis Inc
|
156.30 | 69.92B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 47.07B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.915 | 45.59B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.44 | 19.32B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.04 | 13.10B | 2.99B | 1.21B | 1.13B | 25.06 |
Incannex Healthcare Inc Borsa (IXHL) Ultime notizie
Top Cannabis Stocks To Watch TodayJuly 11th - MarketBeat
Promising Cannabis Stocks To Watch NowJuly 10th - MarketBeat
Best Cannabis Stocks To ResearchJuly 9th - MarketBeat
Incannex Appoints Dr. Kirsch to Advisory Board - TipRanks
Q&A: Innovations in cannabinoid science and commerce - Digital Journal
Incannex Flat on Looking Ahead to Clinical Trial - Baystreet.ca
Incannex Achieves Milestone in Sleep Apnea Drug Trial - TipRanks
Incannex completes database lock for sleep apnea drug trial - Investing.com
Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X - TradingView
Incannex forms joint venture with Mind Medicine Australia for clinic By Investing.com - Investing.com India
Incannex forms joint venture with Mind Medicine Australia for clinic - Investing.com
Incannex Healthcare Announces Psychedelic Therapies Joint Venture - TipRanks
Incannex Healthcare Forms Joint Venture With Mind Medicine Australia To Expand Access To Psychedelic-Assisted Therapy - MarketScreener
Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy - The Manila Times
Incannex Healthcare Inc. Forms Joint Venture with Mind Medicine Australia for Psychedelic-Assisted Therapy Clinic in Melbourne - Nasdaq
Groundbreaking Partnership: Incannex and Mind Medicine Launch Australia's Largest Psychedelic Therapy Center - Stock Titan
Incannex Healthcare Seeks Nasdaq Transfer to Meet Listing Rules By Investing.com - Investing.com Canada
Incannex Healthcare Seeks Nasdaq Transfer to Meet Listing Rules - Investing.com
Incannex Healthcare Transfers Listing to Nasdaq Capital Market - TipRanks
Incannex Healthcare Cancels Series A Warrants - TipRanks
Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution - The Manila Times
Incannex Cancels All Warrants, Removes 347M Share Dilution Before Critical Sleep Apnea Trial Data - Stock Titan
Intriguing 10% Plunge in Incannex Healthcare: What’s Behind the Sudden Drop? - AInvest
Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) - Revista ADVFN
Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates - mx.advfn.com
Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance - mx.advfn.com
Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules - mx.advfn.com
Incannex Expands Advisory Board for OSA Program - TipRanks
Incannex Healthcare Inc. Appoints Four Experts to IHL-42X Obstructive Sleep Apnea Clinical Advisory Board - Nasdaq
Harvard and Emory Leaders Join Incannex's Sleep Apnea Program Ahead of Critical Phase 2 Data - Stock Titan
Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program - TradingView
Incannex Healthcare's 12% Plunge: Technical Sell-Off or Hidden Catalyst? - AInvest
Cannabis Stocks To Add to Your Watchlist – May 29th - Defense World
Incannex advances to phase 3 trial for sleep apnea treatment By Investing.com - Investing.com South Africa
Cannabis Stocks To ResearchMay 25th - MarketBeat
Cannabis Stocks To Consider – May 28th - Defense World
Incannex Healthcare Advances RePOSA Trial to Phase 3 - TipRanks
Incannex advances to phase 3 trial for sleep apnea treatment - Investing.com Australia
Incannex Healthcare Advances IHL-42X Reposa Trial To Phase 3 Following FDA Protocol Clearance - marketscreener.com
Breakthrough: FDA Green-Lights Phase 3 Trial for Revolutionary Oral Sleep Apnea Treatment - Stock Titan
Incannex cancels remaining Series A Warrants to reduce dilution By Investing.com - Investing.com South Africa
Promising Cannabis Stocks Worth Watching – May 27th - Defense World
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - BioSpace
Incannex Cancels Series A Warrants to Strengthen Capital - TipRanks
Incannex cancels remaining Series A Warrants to reduce dilution - Investing.com
Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results - The Manila Times
Incannex Cancels 347M Share Warrant Dilution Before Crucial Sleep Apnea Drug Data Release - Stock Titan
Incannex Healthcare Amends ATM Sales Agreement - TipRanks
SEC Form 424B5 filed by Incannex Healthcare Inc. - Quantisnow
Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Incannex Healthcare Inc Azioni (IXHL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.89%
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):